Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Greenrise Global Brands Inc C.XCX

Healthcare
Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.


CSE:XCX - Post by User

Greenrise Global Brands Inc > AMP German Cannabis: Letter to Shareholder - Preview 2021
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Post by Stockwonderon Dec 16, 2020 5:31am
183 Views
Post# 32116582

AMP German Cannabis: Letter to Shareholder - Preview 2021

AMP German Cannabis: Letter to Shareholder - Preview 2021AMP is ready for german & european market.

'The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally.'

'...in December, the European Union (EU) removed all uncertainty that cannabis with CBD and THC below 0.2% is not a narcotic, which may result in these wellness products being sold without a prescription in Germany and Europe.'

'...AMP import licences for medical cannabis products imported from outside and within the EU into Germany'

'...also received an AmRadV license, which allows us to import irradiated cannabis products from within and outside the EU, which have undergone microbial germ reduction from The Federal Institute for Drugs and Medical Devices (BfArM). '

'...building a strong sales team with the objective to have national coverage'

Click here to read LETTER to shareholders! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities